Shandong Gross Profit vs Research Development Analysis

000756 Stock

16.21 0.14 0.87%

Shandong Xinhua financial indicator trend analysis is much more than just breaking down Shandong Xinhua Phar prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Shandong Xinhua Phar is a good investment. Please check the relationship between Shandong Xinhua Gross Profit and its Research Development accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shandong Xinhua Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Gross Profit vs Research Development

Gross Profit vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Shandong Xinhua Phar Gross Profit account and Research Development. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Shandong Xinhua's Gross Profit and Research Development is 0.9. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Research Development in the same time period over historical financial statements of Shandong Xinhua Pharmaceutical, assuming nothing else is changed. The correlation between historical values of Shandong Xinhua's Gross Profit and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of Shandong Xinhua Pharmaceutical are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Gross Profit i.e., Shandong Xinhua's Gross Profit and Research Development go up and down completely randomly.

Correlation Coefficient

0.9

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Shandong Xinhua Pharmaceutical minus its cost of goods sold. It is profit before Shandong Xinhua operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Research Development

Most indicators from Shandong Xinhua's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Shandong Xinhua Phar current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Shandong Xinhua Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 52.1 M, whereas Selling General Administrative is forecasted to decline to about 800.1 M.

	2021	2022	2023	2024 (projected)
Gross Profit	1.8B	2.0B	2.4B	1.8B
Total Revenue	6.6B	7.5B	8.1B	6.2B

Gross Profit Total Revenue

Shandong Xinhua fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Non Current Assets Total	Non Currrent Assets Other	Short Term Investments
Total Assets		0.18	0.82	0.99	0.81	0.98	1.0	0.94	0.93	-0.73	0.46	0.36	0.97	0.76	-0.42	0.97	0.89	-0.7	0.99	-0.19	0.98	0.96	0.99	0.99	0.03	-0.43
Other Current Liab	0.18		0.04	0.09	0.37	0.27	0.18	0.02	0.13	-0.09	0.02	-0.68	0.29	0.66	0.6	0.33	0.29	-0.25	0.12	-0.12	0.24	0.18	0.15	0.18	0.37	0.41
Total Current Liabilities	0.82	0.04		0.77	0.53	0.72	0.82	0.76	0.78	-0.36	-0.01	0.44	0.78	0.59	-0.59	0.85	0.56	-0.35	0.83	0.18	0.77	0.78	0.77	0.8	-0.19	-0.3
Total Stockholder Equity	0.99	0.09	0.77		0.8	0.98	0.99	0.95	0.92	-0.74	0.53	0.41	0.95	0.69	-0.46	0.92	0.9	-0.69	0.99	-0.21	0.96	0.96	0.99	0.98	0.04	-0.45
Other Liab	0.81	0.37	0.53	0.8		0.85	0.81	0.78	0.8	-0.58	0.47	-0.06	0.81	0.8	-0.09	0.8	0.77	-0.56	0.79	-0.2	0.78	0.76	0.81	0.79	0.26	-0.38
Net Tangible Assets	0.98	0.27	0.72	0.98	0.85		0.98	0.94	0.89	-0.73	0.52	0.28	0.97	0.77	-0.34	0.93	0.92	-0.71	0.97	-0.25	0.97	0.96	0.99	0.97	0.11	-0.37
Retained Earnings	1.0	0.18	0.82	0.99	0.81	0.98		0.94	0.92	-0.73	0.44	0.39	0.96	0.73	-0.44	0.96	0.89	-0.69	0.99	-0.16	0.98	0.95	0.99	0.99	0.02	-0.39
Accounts Payable	0.94	0.02	0.76	0.95	0.78	0.94	0.94		0.87	-0.64	0.45	0.51	0.89	0.59	-0.56	0.87	0.78	-0.64	0.94	-0.24	0.89	0.92	0.94	0.92	-0.01	-0.46
Cash	0.93	0.13	0.78	0.92	0.8	0.89	0.92	0.87		-0.6	0.52	0.3	0.9	0.76	-0.33	0.91	0.76	-0.77	0.96	-0.3	0.86	0.86	0.88	0.89	0.06	-0.35
Other Assets	-0.73	-0.09	-0.36	-0.74	-0.58	-0.73	-0.73	-0.64	-0.6		-0.62	-0.34	-0.67	-0.48	0.12	-0.67	-0.86	0.65	-0.69	0.32	-0.8	-0.62	-0.72	-0.77	-0.28	0.46
Long Term Debt	0.46	0.02	-0.01	0.53	0.47	0.52	0.44	0.45	0.52	-0.62		0.06	0.52	0.41	0.18	0.34	0.58	-0.71	0.49	-0.79	0.44	0.49	0.47	0.43	0.55	-0.33
Net Receivables	0.36	-0.68	0.44	0.41	-0.06	0.28	0.39	0.51	0.3	-0.34	0.06		0.2	-0.3	-0.83	0.23	0.21	-0.19	0.4	0.05	0.33	0.31	0.37	0.36	-0.4	-0.29
Inventory	0.97	0.29	0.78	0.95	0.81	0.97	0.96	0.89	0.9	-0.67	0.52	0.2		0.85	-0.29	0.95	0.88	-0.69	0.96	-0.26	0.95	0.98	0.96	0.96	0.16	-0.4
Other Current Assets	0.76	0.66	0.59	0.69	0.8	0.77	0.73	0.59	0.76	-0.48	0.41	-0.3	0.85		0.16	0.84	0.7	-0.63	0.73	-0.29	0.76	0.75	0.71	0.75	0.32	-0.22
Other Stockholder Equity	-0.42	0.6	-0.59	-0.46	-0.09	-0.34	-0.44	-0.56	-0.33	0.12	0.18	-0.83	-0.29	0.16		-0.33	-0.15	0.05	-0.45	-0.27	-0.37	-0.43	-0.46	-0.43	0.69	0.46
Total Liab	0.97	0.33	0.85	0.92	0.8	0.93	0.96	0.87	0.91	-0.67	0.34	0.23	0.95	0.84	-0.33		0.83	-0.69	0.95	-0.15	0.96	0.91	0.92	0.97	0.02	-0.37
Long Term Investments	0.89	0.29	0.56	0.9	0.77	0.92	0.89	0.78	0.76	-0.86	0.58	0.21	0.88	0.7	-0.15	0.83		-0.62	0.86	-0.16	0.93	0.83	0.91	0.89	0.3	-0.29
Short Long Term Debt	-0.7	-0.25	-0.35	-0.69	-0.56	-0.71	-0.69	-0.64	-0.77	0.65	-0.71	-0.19	-0.69	-0.63	0.05	-0.69	-0.62		-0.73	0.74	-0.67	-0.65	-0.65	-0.68	-0.1	0.23
Total Current Assets	0.99	0.12	0.83	0.99	0.79	0.97	0.99	0.94	0.96	-0.69	0.49	0.4	0.96	0.73	-0.45	0.95	0.86	-0.73		-0.22	0.96	0.96	0.98	0.98	0.01	-0.42
Short Term Debt	-0.19	-0.12	0.18	-0.21	-0.2	-0.25	-0.16	-0.24	-0.3	0.32	-0.79	0.05	-0.26	-0.29	-0.27	-0.15	-0.16	0.74	-0.22		-0.15	-0.24	-0.15	-0.17	-0.35	0.21
Intangible Assets	0.98	0.24	0.77	0.96	0.78	0.97	0.98	0.89	0.86	-0.8	0.44	0.33	0.95	0.76	-0.37	0.96	0.93	-0.67	0.96	-0.15		0.93	0.97	0.99	0.05	-0.43
Common Stock	0.96	0.18	0.78	0.96	0.76	0.96	0.95	0.92	0.86	-0.62	0.49	0.31	0.98	0.75	-0.43	0.91	0.83	-0.65	0.96	-0.24	0.93		0.97	0.95	0.04	-0.45
Property Plant Equipment	0.99	0.15	0.77	0.99	0.81	0.99	0.99	0.94	0.88	-0.72	0.47	0.37	0.96	0.71	-0.46	0.92	0.91	-0.65	0.98	-0.15	0.97	0.97		0.98	0.01	-0.43
Non Current Assets Total	0.99	0.18	0.8	0.98	0.79	0.97	0.99	0.92	0.89	-0.77	0.43	0.36	0.96	0.75	-0.43	0.97	0.89	-0.68	0.98	-0.17	0.99	0.95	0.98		0.0	-0.48
Non Currrent Assets Other	0.03	0.37	-0.19	0.04	0.26	0.11	0.02	-0.01	0.06	-0.28	0.55	-0.4	0.16	0.32	0.69	0.02	0.3	-0.1	0.01	-0.35	0.05	0.04	0.01	0.0		0.13
Short Term Investments	-0.43	0.41	-0.3	-0.45	-0.38	-0.37	-0.39	-0.46	-0.35	0.46	-0.33	-0.29	-0.4	-0.22	0.46	-0.37	-0.29	0.23	-0.42	0.21	-0.43	-0.45	-0.43	-0.48	0.13

Click cells to compare fundamentals

Shandong Xinhua Account Relationship Matchups

Shandong Xinhua fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.4B	7.1B	7.3B	8.3B	8.3B	7.1B
Other Current Liab	685.6M	934.7M	653.5M	85.8M	22.9M	21.8M
Total Current Liabilities	2.5B	2.4B	2.5B	3.2B	2.5B	2.6B
Total Stockholder Equity	3.0B	3.2B	3.5B	4.1B	4.6B	3.3B
Other Liab	199.1M	234.0M	226.0M	208.4M	239.6M	221.9M
Net Tangible Assets	2.4B	2.6B	2.8B	3.0B	3.5B	2.5B
Retained Earnings	1.5B	1.8B	2.0B	2.3B	2.3B	1.7B
Accounts Payable	798.5M	742.9M	1.1B	1.1B	1.2B	952.1M
Cash	690.5M	855.8M	744.7M	1.2B	918.3M	845.2M
Other Assets	98.8M	101.4M	85.7M	94.4M	85.0M	88.1M
Long Term Debt	589.8M	462.7M	346.2M	545.7M	799.4M	571.5M
Net Receivables	474.9M	379.9M	658.6M	761.3M	699.9M	617.7M
Inventory	1.1B	1.1B	1.0B	1.2B	1.3B	1.1B
Other Current Assets	128.2M	155.9M	93.9M	102.9M	89.1M	105.8M
Other Stockholder Equity	183.4M	177.2M	128.4M	113.7M	102.3M	123.4M
Total Liab	3.3B	3.7B	3.7B	3.9B	3.5B	3.6B
Short Long Term Debt	540M	200.4M	269.5M	118.0M	284.0M	289.9M
Total Current Assets	2.4B	2.7B	2.8B	3.5B	3.3B	2.7B
Intangible Assets	411.6M	449.2M	466.5M	474.1M	494.9M	431.5M
Property Plant Equipment	3.2B	3.5B	3.8B	4.0B	4.6B	3.4B
Non Current Assets Total	4.0B	4.4B	4.6B	4.8B	5.0B	4.5B
Non Currrent Assets Other	4.0B	15.9M	14.2M	21.5M	102.9M	97.7M
Non Current Liabilities Total	840.0M	1.3B	1.2B	756.7M	1.0B	1.0B
Net Invested Capital	4.1B	3.9B	4.1B	4.8B	5.6B	4.6B
Net Working Capital	(57.1M)	305.8M	252.1M	298.5M	828.3M	869.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Other Information on Investing in Shandong Stock

Balance Sheet is a snapshot of the financial position of Shandong Xinhua Phar at a specified time, usually calculated after every quarter, six months, or one year. Shandong Xinhua Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Shandong Xinhua and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Shandong currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Shandong Gross Profit vs Research Development Analysis

Gross Profit vs Research Development

Gross Profit vs Research Development Correlation Analysis

Correlation Coefficient

Gross Profit

Research Development

Shandong Xinhua fundamental ratios Correlations

Shandong Xinhua Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Shandong Xinhua fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in Shandong Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Retained Earnings	+ 1.0	Total Assets
Total Stockholder Equity	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Assets
Property Plant Equipment	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Retained Earnings	+ 0.99	Total Stockholder Equity

Long Term Investments	- 0.86	Other Assets
Other Stockholder Equity	- 0.83	Net Receivables
Intangible Assets	- 0.8	Other Assets
Short Term Debt	- 0.79	Long Term Debt
Non Current Assets Total	- 0.77	Other Assets
Short Long Term Debt	- 0.77	Cash